reactive amyloidosis
Recently Published Documents


TOTAL DOCUMENTS

47
(FIVE YEARS 1)

H-INDEX

13
(FIVE YEARS 0)

2021 ◽  
pp. jim-2021-002149
Author(s):  
Baldeep Kaur Mann ◽  
Janpreet Singh Bhandohal ◽  
Everardo Cobos ◽  
Chandrika Chitturi ◽  
Sabitha Eppanapally

Amyloidosis is a rare group of diseases characterized by abnormal folding of proteins and extracellular deposition of insoluble fibrils. It can be localized to one organ system or can have systemic involvement. The kidney is the most common organ to be involved in systemic amyloidosis often leading to renal failure and the nephrotic syndrome. The two most common types of renal amyloidosis are immunoglobulin light chain-derived amyloidosis (AL) and reactive amyloidosis (AA). A novel form of amyloidosis (ALECT2) derived from leukocyte chemotactic factor 2 (LECT-2) and primarily involving the kidneys was first described by Benson et al in 2008. The liver was subsequently identified as the second most common organ involved in ALECT2 amyloidosis. LECT-2 is a unique protein that can form amyloid deposits even in its unmutated form. Patients with ALECT2 present with minimal proteinuria in contrast to other forms of amyloidosis especially AL and AA. They may present with slightly elevated serum creatinine. Nephrotic syndrome and hematuria are rare. ALECT2 can be found in association with other types of amyloidosis as well as malignancies or autoimmune diseases. ALECT2 may be confused with amyloidosis associated with light and heavy chain monoclonal gammopathy if the immunofluorescence is positive with anti-light chain and anti-AA sera. The other organs involved are the duodenum, adrenal gland, spleen, prostate, gall bladder, pancreas, small bowel, parathyroid gland, heart, and pulmonary alveolar septa, but consistently uninvolved organs included brain and fibroadipose tissue. A renal biopsy along with characteristic features found on immunohistochemistry and mass spectrometry is diagnostic of ALECT2. ALECT2 should be suspected when all markers for AL and AA are negative. Proper diagnosis of ALECT2 can determine need for supportive care versus more aggressive interventions.


Author(s):  
Sajjan Mittal

Amyloidosis is a multisystem disease caused by the extracellular deposition of insoluble abnormal fibrils that injure tissues and organs. The fibrils are formed by the aggregation of misfolded, normally soluble proteins. Systemic amyloid light-chain (AL) amyloidosis (primary amyloidosis) is the commonest type of amyloidosis in the developed world, accounting for 80% of cases. The remainder are due to AA amyloidosis (secondary or reactive amyloidosis), familial amyloidosis, or other rare types of amyloidosis. The most common clinical features at diagnosis are nephrotic syndrome, heart failure (typically with predominant right heart failure), sensorimotor and/or autonomic peripheral neuropathy, and hepatosplenomegaly.


2017 ◽  
Vol 4 (3) ◽  
pp. 1-3
Author(s):  
Jayanivash J ◽  
Srinivasa Prasad ND ◽  
Sujit S ◽  
Edwin Fernando M

2015 ◽  
Vol 2015 ◽  
pp. 1-4
Author(s):  
T. Meira ◽  
R. Sousa ◽  
A. Cordeiro ◽  
R. Ilgenfritz ◽  
P. Borralho

We present a case of reactive amyloidosis that developed secondary to common variable immunodeficiency and rheumatoid arthritis. A 66-year-old woman, with prior history of common variable immunodeficiency and rheumatoid arthritis, was referred to our clinic for chronic diarrhea investigation. The patient was submitted to colonoscopy with ileoscopy, which did not show relevant endoscopic alterations. However, undertaken biopsies revealed amyloid deposition. Since amyloidosis with GI involvement is a rare cause of chronic diarrhea, this pathology should be considered in etiologic investigation, especially when associated with chronic inflammatory diseases.


2013 ◽  
Vol 6 (1) ◽  
Author(s):  
Takeshi Kuroda ◽  
Naohito Tanabe ◽  
Hiroe Sato ◽  
Takeshi Nakatsue ◽  
Yoko Wada ◽  
...  

2013 ◽  
Vol 7 (3) ◽  
pp. 476-481 ◽  
Author(s):  
Vinaya Gaduputi ◽  
Hassan Tariq ◽  
Kanthi Badipatla ◽  
Ariyo Ihimoyan

2012 ◽  
Vol 72 (3) ◽  
pp. 464-465 ◽  
Author(s):  
Markku Hakala ◽  
Kai Immonen ◽  
Markku Korpela ◽  
Mikko Vasala ◽  
Markku J Kauppi

2012 ◽  
Vol 24 (6) ◽  
pp. 1184-1188 ◽  
Author(s):  
David X. Liu ◽  
Margaret H. Gilbert ◽  
Xiaolei Wang ◽  
Peter J. Didier ◽  
Ronald S. Veazey
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document